glp-1 medications and anesthesia Are Serious Risks of Semaglutide Other Agonists Under-Recognized? Case Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia GLP-1 agonists and anesthesia risk:

However, not all injections are created equal

EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCdelta, and sphingosine kinase 1 in glioblastoma cells

Combining Sermorelin and Ipamorelin targets both GHRH receptors (Sermorelin) and ghrelin receptors (Ipamorelin) simultaneously, potentially producing complementary GH stimulation through different pathways

Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors (SGLT2i) independently reduce CV and kidney events

L., Huo, T

The general takeaway is that his glycemic control was close to goal while on dulaglutide 1.5 mg weekly and insulin glargine 18 units daily